- Home
- AGL vs FBRX Comparison
AGL vs FBRX Comparison
Compare AGL & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$0.72
HOLD
Current Price
$21.41
Company Overview
Basic Information| Metric | AGL | FBRX |
|---|---|---|
| Founded | 2016 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Managed Health Care | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 270.4M | 253.7M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | AGL | FBRX |
|---|---|---|
| Price | $0.72 | $21.41 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 17 | 4 |
| Target Price | $2.79 | ★ $67.00 |
| AVG Volume (30 Days) | ★ 10.5M | 120.2K |
| Earning Date | 11-04-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $5,885,571,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.40 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 5.21 | N/A |
| 52 Week Low | $0.51 | $4.90 |
| 52 Week High | $6.08 | $25.97 |
Technical Indicators
Market Signals| Indicator | AGL | FBRX |
|---|---|---|
| Relative Strength Index (RSI) | 52.67 | 64.32 |
| Support Level | $0.64 | $18.85 |
| Resistance Level | $0.72 | $21.45 |
| Average True Range (ATR) | 0.06 | 2.00 |
| MACD | 0.02 | 0.14 |
| Stochastic Oscillator | 91.14 | 66.30 |
Price Performance
Historical Comparison AGL
FBRX
About AGL agilon health inc.
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).